Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-03-20

FDA Approved: COUNTERACT ALLERGY — Supplemental Application (Melaleuca, Inc.)

View source ↗

Summary

FDA approved a supplemental application for COUNTERACT ALLERGY (loratadine) from Melaleuca, Inc. This approval confirms the product as an approved loratadine-co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • COUNTERACT ALLERGY (Loratadine)

Snippet

SUPPL AP for COUNTERACT ALLERGY (LORATADINE)